Skip to main content
Image
Ona Therapeutics raises $86.6 M Series B to advance first-in-class ADCs into clinical development

The financing supports Ona Therapeutics, an IRB Barcelona and ICREA spin-off, in its transition to a clinical-stage company.

Image
HelixAI: New spin-off from IRB Barcelona, ICREA, and UPC to transform biomedical data into clinical insight using AI

HelixAI, the ninth spin-off for IRB Barcelona, integrates multi-omic data to drive both biomedical research and clinical practice.

Image
Two open Group Leader positions

IRB Barcelona invites applications for two Group Leader positions, one in Chemical Biology and one in Structural Biology, as part of its strategic effort to strengthen the molecular sciences.

Image
Cancer doesn't wait campaign

IRB Barcelona launches the Cancer doesn't wait campaign to raise funds for cancer and metastasis research.

Image
Dr. Núria López-Bigas, awarded the Rei Jaume I Prize for Biomedical Research

The award ceremony was held in Valencia on 25 November, bringing together the scientific and institutional community to celebrate excellence in research.

Upcoming Events